Which has the lower trailing P/E, AMPH or OMDA?

AMPH has the lower trailing P/E: AMPH trades at 15.27 and OMDA at 326.35. P/E is one valuation measure and does not by itself establish which business is cheaper.

Is AMPH or OMDA more profitable?

AMPH runs the higher net margin — AMPH at 10.76% versus OMDA at 1.39%.

Amphastar Pharmaceuticals, Inc. (AMPH) vs Omada Health (OMDA)

A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Omada Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AMPH

Amphastar Pharmaceuticals, Inc.

$1.14B

$25.80HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

OMDA

Omada Health

$1.22B

$20.56HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

Total return — AMPH vs OMDA

growth of $100 · dividends reinvested · last 1y

AMPH -1.9% (-1.9%/yr)OMDA -8.9% (-8.9%/yr)AMPH compounded faster over this window

AMPH OMDA

AMPH vs OMDA: by the numbers

•OMDA is the larger company ($1.22B vs $1.14B market cap).
•AMPH trades at the lower trailing earnings multiple (15.27 vs 326.35 P/E), one valuation lens rather than an overall verdict.
•AMPH converts more revenue to profit (10.76% vs 1.39% net margin).

Metrics side by side

Valuation

Metric	AMPH	OMDA
P/E ratio	15.27	326.35
Forward P/E	8.68	N/A
PEG ratio	0.11	N/A
P/S ratio	1.56	3.95
P/B ratio	1.48	4.84
EV / EBITDA	8.93	144.19
FCF yield	13.44%	1.64%

Profitability

Metric	AMPH	OMDA
Gross margin	47.68%	68.19%
Operating margin	15.66%	-0.15%
Net margin	10.76%	1.39%
ROE	10.23%	1.70%
ROIC	5.93%	-0.18%

Growth (annualized)

Metric	AMPH	OMDA
Revenue CAGR (5Y)	13.71%	N/A
EPS CAGR (5Y)	134.23%	N/A
FCF CAGR (5Y)	23.90%	N/A
Total return CAGR (5Y)	6.13%	N/A

Frequently asked

Which has the lower trailing P/E, AMPH or OMDA?: AMPH has the lower trailing P/E: AMPH trades at 15.27 and OMDA at 326.35. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is AMPH or OMDA more profitable?: AMPH runs the higher net margin — AMPH at 10.76% versus OMDA at 1.39%.

Go deeper

Full AMPH analysis Full OMDA analysis Interactive comparison tool

Dig into the metrics

Amphastar Pharmaceuticals P/E ratio Omada Health P/E ratio Amphastar Pharmaceuticals ROE Omada Health ROE Amphastar Pharmaceuticals operating margin Omada Health operating margin Amphastar Pharmaceuticals revenue growth Omada Health revenue growth Amphastar Pharmaceuticals free cash flow Omada Health free cash flow

Amphastar Pharmaceuticals & Omada Health appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.